Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
AIM ImmunoTech Inc. (AIM) had Return on Equity of -44.42% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$0.02M |
|
$-3.14M |
|
$0.01M |
|
$0.01M |
|
$2.98M |
|
$-2.96M |
|
$-0.19M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-2.96M |
|
$-2.68M |
|
32.49M |
|
32.49M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$7.34M |
|
$0.05M |
|
$2.42M |
|
$9.75M |
|
$2.67M |
|
-- |
|
$0.00M |
|
$2.67M |
|
$7.08M |
|
$5.32M |
|
$7.08M |
|
39.90M |
|
| Cash Flow Statement Financials | |
$-10.24M |
|
$-0.23M |
|
$14.37M |
|
$2.98M |
|
$6.89M |
|
$3.90M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.75 |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
68.18% |
|
-13440.91% |
|
-13440.91% |
|
-- |
|
-14286.37% |
|
-14286.36% |
|
$-10.24M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-44.42% |
-59.12% |
|
-32.23% |
|
-44.42% |
|
$0.18 |
|
$-0.32 |
|
$-0.32 |
|